These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10072501)

  • 1. Functional analysis of TRAIL receptors using monoclonal antibodies.
    Griffith TS; Rauch CT; Smolak PJ; Waugh JY; Boiani N; Lynch DH; Smith CA; Goodwin RG; Kubin MZ
    J Immunol; 1999 Mar; 162(5):2597-605. PubMed ID: 10072501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
    J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
    Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
    Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
    Zhang XD; Franco A; Myers K; Gray C; Nguyen T; Hersey P
    Cancer Res; 1999 Jun; 59(11):2747-53. PubMed ID: 10364001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
    Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
    Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution of the death ligand TRAIL and its receptors.
    Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
    J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
    Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
    Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A; Grotzer MA; Zuzak TJ; Wiewrodt BR; Ho R; Ikegaki N; Brodeur GM
    Cancer Res; 2001 Feb; 61(4):1314-9. PubMed ID: 11245427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.
    Wendling U; Walczak H; Dörr J; Jaboci C; Weller M; Krammer PH; Zipp F
    Cell Death Differ; 2000 Jul; 7(7):637-44. PubMed ID: 10889508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TRAIL and its receptors in human brain tumors.
    Frank S; Köhler U; Schackert G; Schackert HK
    Biochem Biophys Res Commun; 1999 Apr; 257(2):454-9. PubMed ID: 10198234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases.
    Harper N; Farrow SN; Kaptein A; Cohen GM; MacFarlane M
    J Biol Chem; 2001 Sep; 276(37):34743-52. PubMed ID: 11461927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants of response to TRAIL in killing of normal and cancer cells.
    Kim K; Fisher MJ; Xu SQ; el-Deiry WS
    Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of a set of monoclonal antibodies to TRAIL and TRAIL receptors DR4, DR5, DcR1, and DcR2.
    Liu XS; Zhu Y; Han WN; Li YN; Chen LH; Jia W; Song CJ; Liu F; Yang K; Li Q; Jin BQ
    Hybrid Hybridomics; 2003 Apr; 22(2):121-5. PubMed ID: 12831538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains.
    Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C
    J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
    Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
    Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
    Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL induces death of human oligodendrocytes isolated from adult brain.
    Matysiak M; Jurewicz A; Jaskolski D; Selmaj K
    Brain; 2002 Nov; 125(Pt 11):2469-80. PubMed ID: 12390973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
    Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
    Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy.
    Lincz LF; Yeh TX; Spencer A
    Leukemia; 2001 Oct; 15(10):1650-7. PubMed ID: 11587225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.